NOK 14.0
(-6.35%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -41.89 Million NOK | 3.19% |
2022 | -43.27 Million NOK | -135.9% |
2021 | -18.34 Million NOK | -59.85% |
2020 | -11.47 Million NOK | 21.34% |
2019 | -14.58 Million NOK | 31.6% |
2018 | -21.32 Million NOK | -1041.26% |
2017 | 2.26 Million NOK | 2043.37% |
2016 | 105.71 Thousand NOK | 126.14% |
2015 | -404.43 Thousand NOK | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | -89.18 Million NOK | -203.13% |
2024 Q1 | -29.42 Million NOK | 29.78% |
2023 Q2 | -19.13 Million NOK | 45.73% |
2023 Q4 | -41.89 Million NOK | -139.78% |
2023 FY | -41.89 Million NOK | 3.19% |
2023 Q1 | -35.26 Million NOK | 18.52% |
2023 Q3 | -17.47 Million NOK | 8.7% |
2022 Q3 | -11.39 Million NOK | -132.92% |
2022 FY | -43.27 Million NOK | -135.9% |
2022 Q2 | -4.89 Million NOK | 0.0% |
2022 Q4 | -43.27 Million NOK | -279.94% |
2021 Q4 | -18.34 Million NOK | 0.0% |
2021 FY | -18.34 Million NOK | -59.85% |
2021 Q2 | -1.5 Million NOK | 0.0% |
2020 Q4 | -11.47 Million NOK | 0.0% |
2020 FY | -11.47 Million NOK | 21.34% |
2019 Q4 | -14.58 Million NOK | 0.0% |
2019 Q2 | -18.17 Million NOK | 0.0% |
2019 FY | -14.58 Million NOK | 31.6% |
2018 Q4 | -21.32 Million NOK | 0.0% |
2018 Q2 | 2.04 Million NOK | 0.0% |
2018 FY | -21.32 Million NOK | -1041.26% |
2017 FY | 2.26 Million NOK | 2043.37% |
2017 Q4 | 2.26 Million NOK | 0.0% |
2016 FY | 105.71 Thousand NOK | 126.14% |
2015 FY | -404.43 Thousand NOK | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Gentian Diagnostics ASA | -78.63 Million NOK | 46.723% |
Medistim ASA | -144.61 Million NOK | 71.029% |